These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36351380)

  • 1. Toll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer.
    Millar FR; Pennycuick A; Muir M; Quintanilla A; Hari P; Freyer E; Gautier P; Meynert A; Grimes G; Coll CS; Zdral S; Victorelli S; Teixeira VH; Connelly J; Passos JF; Ros MA; Wallace WAH; Frame MC; Sims AH; Boulter L; Janes SM; Wilkinson S; Acosta JC
    Cell Rep; 2022 Nov; 41(6):111596. PubMed ID: 36351380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype.
    Hari P; Millar FR; Tarrats N; Birch J; Quintanilla A; Rink CJ; Fernández-Duran I; Muir M; Finch AJ; Brunton VG; Passos JF; Morton JP; Boulter L; Acosta JC
    Sci Adv; 2019 Jun; 5(6):eaaw0254. PubMed ID: 31183403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-positive pneumonia augments non-small cell lung cancer metastasis via host toll-like receptor 2 activation.
    Gowing SD; Chow SC; Cools-Lartigue JJ; Chen CB; Najmeh S; Jiang HY; Bourdeau F; Beauchamp A; Mancini U; Angers I; Giannias B; Spicer JD; Rousseau S; Qureshi ST; Ferri LE
    Int J Cancer; 2017 Aug; 141(3):561-571. PubMed ID: 28401532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence-Associated Secretory Phenotype Suppression Mediated by Small-Sized Mesenchymal Stem Cells Delays Cellular Senescence through TLR2 and TLR5 Signaling.
    Kwon JH; Kim M; Um S; Lee HJ; Bae YK; Choi SJ; Hwang HH; Oh W; Jin HJ
    Cells; 2021 Jan; 10(1):. PubMed ID: 33401590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
    Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
    Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways.
    Liu YD; Ji CB; Li SB; Yan F; Gu QS; Balic JJ; Yu L; Li JK
    Int Immunopharmacol; 2018 Jun; 59():375-383. PubMed ID: 29689497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.
    Yoshida H; Jono H; Kai H; Li JD
    J Biol Chem; 2005 Dec; 280(49):41111-21. PubMed ID: 16230348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer.
    West AC; Tang K; Tye H; Yu L; Deng N; Najdovska M; Lin SJ; Balic JJ; Okochi-Takada E; McGuirk P; Keogh B; McCormack W; Bhathal PS; Reilly M; Oshima M; Ushijima T; Tan P; Jenkins BJ
    Oncogene; 2017 Sep; 36(36):5134-5144. PubMed ID: 28481875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
    Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions.
    Jha SK; De Rubis G; Devkota SR; Zhang Y; Adhikari R; Jha LA; Bhattacharya K; Mehndiratta S; Gupta G; Singh SK; Panth N; Dua K; Hansbro PM; Paudel KR
    Ageing Res Rev; 2024 Jun; 97():102315. PubMed ID: 38679394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF8 induces senescence of lung cancer cells to exert its tumor suppressive function.
    Liang J; Lu F; Li B; Liu L; Zeng G; Zhou Q; Chen L
    Cell Cycle; 2019 Dec; 18(23):3300-3312. PubMed ID: 31594449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 mediates Acanthamoeba-induced allergic airway inflammatory response in mice.
    Park MK; Park HK; Yu HS
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011085. PubMed ID: 36706056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
    Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
    J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2.
    Kong D; Wang Z; Tian J; Liu T; Zhou H
    J Cell Physiol; 2019 Apr; 234(4):4597-4607. PubMed ID: 30203548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role.
    Lau L; Porciuncula A; Yu A; Iwakura Y; David G
    Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing of Toll-like receptor 2 inhibits proliferation of human liver cancer cells and secretion of inflammatory cytokines.
    Huang Y; Cai B; Xu M; Qiu Z; Tao Y; Zhang Y; Wang J; Xu Y; Zhou Y; Yang J; Han X; Gao Q
    PLoS One; 2012; 7(7):e38890. PubMed ID: 22815694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8
    Xu J; Guo R; Jia J; He Y; He S
    BMC Immunol; 2021 Oct; 22(1):67. PubMed ID: 34620075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 mediates endogenous TLR2 activation and brain tumor regression.
    Curtin JF; Liu N; Candolfi M; Xiong W; Assi H; Yagiz K; Edwards MR; Michelsen KS; Kroeger KM; Liu C; Muhammad AK; Clark MC; Arditi M; Comin-Anduix B; Ribas A; Lowenstein PR; Castro MG
    PLoS Med; 2009 Jan; 6(1):e10. PubMed ID: 19143470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3.
    Tripathi U; Nchioua R; Prata LGPL; Zhu Y; Gerdes EOW; Giorgadze N; Pirtskhalava T; Parker E; Xue A; Espindola-Netto JM; Stenger S; Robbins PD; Niedernhofer LJ; Dickinson SL; Allison DB; Kirchhoff F; Sparrer KMJ; Tchkonia T; Kirkland JL
    Aging (Albany NY); 2021 Sep; 13(18):21838-21854. PubMed ID: 34531331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.